Drugs and Devices

Potential new treatment for SRI-resistant patients with depression

S-adenosyl methionine (SAMe), a naturally occurring molecule, may be an effective treatment for patients with depression who don’t respond to serotonin reuptake inhibitors (SRIs) according to a study of 73 patients in the American Journal of Psychiatry. Read more here.


Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares